Expertise in
22
conditions

Dr. Srinivas K. Tantravahi

Hematology
1950 Circle Of Hope Dr, 
Salt Lake City, UT 
Accepting New Patients
Offers Telehealth
Expertise in
22
conditions
1950 Circle Of Hope Dr, 
Salt Lake City, UT 

Overview

Srinivas Tantravahi is a Hematologist practicing medicine in Salt Lake City, Utah.

Dr. Tantravahi is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Myelofibrosis, Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Tantravahi is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 3 clinical trials. Dr. Tantravahi is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in UT

Board Certifications

American Board Of Internal Medicine

Hospital Affiliations

Bozeman Health Deaconess Hospital
University Of Utah Hospital And Clinics
Memorial Hospital Sweetwater County
Mountain View Hospital

Languages Spoken

English
Hindi
Telugu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Regence
  • EPO
  • PPO
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
SelectHealth
  • HMO
  • POS
Steward Health Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Huntsman Cancer Institute, Hematology-oncology
1950 Circle Of Hope Dr, Salt Lake City, UT 84112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis
A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug, Other
Study Drug: Selinexor
Study Phase: Phase 2
A Phase 1/3 Study to Evaluate Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Ruxolitinib in Treatment-naïve Patients With Myelofibrosis
A Phase 1/3 Study to Evaluate Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Ruxolitinib in Treatment-naïve Patients With Myelofibrosis
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2026
Intervention Type: Other, Drug
Study Drugs: Selinexor, Ruxolitinib
Study Phase: Phase 3
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination With BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients With Molecular Evidence of Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2025
Intervention Type: Drug, Other
Study Drugs: Bosutinib, Dasatinib, Nilotinib, Nilotinib Hydrochloride Monohydrate, Ruxolitinib, Ruxolitinib Phosphate
Study Phase: Phase 2
View 2 Less Clinical Trials

56 Total Publications

Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes.
Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes.
Journal: Expert review of hematology
Published: August 12, 2026
Similar Doctors
Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required
2000 Cir of Hope Dr, 
Salt Lake City, UT 
 (0.1 miles away)
801-585-3229
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Narendranath Epperla is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Epperla is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Epperla is board certified in American Board Of Internal Medicine. Dr. Epperla is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Univ. Of Utah Hosp. Im-Hematology-Hematologic

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 (0.1 miles away)
801-585-3229
Languages Spoken:
English, Czech, German, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Josef Prchal is a Hematologist practicing medicine in Salt Lake City, Utah. Dr. Prchal is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant. Dr. Prchal is board certified in American Board Of Internal Medicine. Dr. Prchal is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Huntsman Cancer Institute Bmt

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 (0.1 miles away)
801-585-2626
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Sborov is a Hematologist practicing medicine in Salt Lake City, Utah. He has been practicing medicine for over 17 years. Dr. Sborov is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Sborov is board certified in American Board Of Internal Medicine. Dr. Sborov is currently accepting new patients.

Frequently Asked Questions about Dr. Srinivas K. Tantravahi

How do I make an appointment with Dr. Srinivas K. Tantravahi?

You can book an appointment with Dr. Srinivas K. Tantravahi by calling their office at 801-585-0100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Srinivas K. Tantravahi a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Srinivas K. Tantravahi is classified as an Elite expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Srinivas K. Tantravahi specialize in?

While Dr. Srinivas K. Tantravahi is a Hematology, they have specific expertise in Chronic Myelogenous Leukemia (CML), Myelofibrosis, and Chronic Myelomonocytic Leukemia (CMML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Srinivas K. Tantravahi participate in research or clinical trials?

Yes. Dr. Srinivas K. Tantravahi has published 56 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Dr. Srinivas K. Tantravahi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Srinivas K. Tantravahi accept my insurance?

Dr. Srinivas K. Tantravahi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 801-585-0100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tantravahi's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 13 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile